The groups were compared in terms of ultrasonographic features, baseline hematological parameters, and thyroid hormone sensitivity indices.<h4>Results</h4>A total of 185 patients with thyroid nodules initially classified as Bethesda category III (AUS) were included, and 30.8% of surgically treated cases were malignant. This evidence concerns the gene TG and thyroid nodule.